|
Catalogue
Number
|
Product
|
Order number / Unit
|
|
|
1310
|
6-Fluoro-L-DOPA hydrochloride
|
1310.0005: 5 mg per vial
1310.0010: 10 mg per vial
Please inquire for customized
filling and bulk quantities.
|
|
|
Reference standard for 6-[18F]Fluoro-L-DOPA
|
|
|
|
|
|
|
|
|
Molar Mass: 251.64
|
|
|
C9H10FNO4 ⋅ HCl
|
|
|
[144334-59-8]
|
|
|
|
|
|
Nearly colourless solid packaged in dark glass screw cap vials.
|
|
|
|
|
|
|
|
|
Purity: > 95 %
|
|
|
Certificates:
CoA; 1H and 19F NMR spectra, HPLC
|
|
|
Chemical Name:
CA index name: L-Tyrosine, 2-fluoro-5-hydroxy-, hydrochloride
|
|
|
Synonymes:
2-Fluoro-5-hydroxyl-L-tyrosine hydrochloride; 6-Fluoro-L-DOPA hydrochloride; 6-Fluoro-DOPA-hydrochloride; F-L-DOPA ⋅ HCl; FDOPA
|
|
|
Literature:
1. Namavari M. et al. Regioselective Radiofluorodestannylation with [18F]CH3COOF: a High Yield Synthesis of 6-[18F]Fluoro-L-dopa. Appl. Radiot. Isot., Int. J. Radiat. Appl. Instrum. Part A 1992, 43, 989-996.
|
|
|
2. Iwata R. et al. Regioselective Synthesis of 6-[18F]-Fluoro-L-dopa via Radiofluorodestannylation. CYRIC Annual Report, 1997, 99-102.
|
|
|
3. Dolle F. et al. 6-[18F]Fluoro L DOPA by Radiofluorodestannylation: A Short and Simple Synthesis of a New Labelling Precursor. J. Labelled Compd. Radiopharm. 1998, 41, 105-114.
|
|
|
|
|
|
|
|
|
date of product catalogue issue:
22 December 2011
|